Your browser doesn't support javascript.
loading
An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents.
Anton-Paduraru, Dana-Teodora; Murgu, Alina Mariela; Donos, Madalina Andreea; Trofin, Felicia; Azoicai, Alice Nicoleta; Popovici, Paula; Stana, Aurelian Bogdan; Gheorghiescu, Ionela; Trandafir, Laura Mihaela.
Afiliação
  • Anton-Paduraru DT; Department of Mother and Child Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Murgu AM; "Sf. Maria" Children Emergency Hospital, 700309 Iasi, Romania.
  • Donos MA; Department of Mother and Child Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Trofin F; "Sf. Maria" Children Emergency Hospital, 700309 Iasi, Romania.
  • Azoicai AN; Department of Mother and Child Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Popovici P; "Sf. Maria" Children Emergency Hospital, 700309 Iasi, Romania.
  • Stana AB; Department of Preventive Medicine and Interdisciplinarity-Microbiology, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
  • Gheorghiescu I; Clinical Hospital of Infectious Diseases "Sf. Parascheva", 700116 Iasi, Romania.
  • Trandafir LM; Department of Mother and Child Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
Children (Basel) ; 10(12)2023 Nov 30.
Article em En | MEDLINE | ID: mdl-38136081
ABSTRACT
This paper delineates several aspects of cystic fibrosis-related diabetes (CFRD)-a common complication of cystic fibrosis (CF). CFRD exhibits a predilection for older individuals with CF, yet it also extends its influence on children and adolescents. Scientific insights postulate a potential link between CFRD and the aberrant mucus production within the pancreas, thereby culminating in pancreatic insufficiency. This, in turn, perturbs the synthesis of insulin, a pivotal endocrine hormone responsible for the regulation of glycemic levels. Standardized protocols advocate for the systematic screening of CFRD among all individuals with CF, commencing at the age of 10 years using the oral glucose tolerance test (OGTT). Therapeutic modalities encompass insulin therapy, dietary adjustments, and the vigilant monitoring of glycemic parameters. The overarching objective is to maintain blood glucose levels within a targeted range to mitigate the advent of diabetic complications. Untreated or sub-optimally managed CFRD can precipitate a spectrum of deleterious health ramifications, encompassing cardiovascular afflictions, neuropathy, renal dysfunction, and ocular complications.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article